TXNIP

TXNIP
PDBに登録とうろくされている構造こうぞう
PDB	オルソログ検索けんさく: RCSB PDBe PDBj
PDBのIDコード一覧いちらん
	4GEI, 4GEJ, 4GFX, 4LL1, 4LL4, 4ROF, 4ROJ, 5CQ2, 5DF6, 5DWS, 5DZD
識別子しきべつし
記号きごう	TXNIP, thioredoxin interacting protein, EST01027, HHCPA78, THIF, VDUP1, ARRDC6
外部がいぶID	OMIM: 606599 MGI: 1889549 HomoloGene: 38186 GeneCards: TXNIP
遺伝子いでんしの位置いち (ヒト)
染色せんしょく体たい	1番ばん染色せんしょく体たい (ヒト)
終点しゅうてん	145,996,579 bp
遺伝子いでんしの位置いち (マウス)
染色せんしょく体たい	3番ばん染色せんしょく体たい (マウス)
終点しゅうてん	96,469,199 bp
RNA発現はつげんパターン
	; ; ; ;
	さらなる参照さんしょう発現はつげんデータ
遺伝子いでんしオントロジー
分子ぶんし機能きのう	• enzyme inhibitor activity; • 血漿けっしょうタンパク結合けつごう; • ubiquitin protein ligase binding;
細胞さいぼうの構成こうせい要素ようそ	• 細胞さいぼう質しつ; • 細胞さいぼう質しつ基質きしつ; • mitochondrial intermembrane space; • 細胞さいぼう核かく;
生物せいぶつ学がく的てきプロセス	• cellular response to tumor cell; • エストラジオールへの反応はんのう; • negative regulation of catalytic activity; • regulation of transcription, DNA-templated; • protein import into nucleus; • response to progesterone; • response to mechanical stimulus; • negative regulation of transcription by RNA polymerase II; • response to glucose; • 酸化さんかストレスへの反応はんのう; • transcription, DNA-templated; • keratinocyte differentiation; • response to calcium ion; • negative regulation of cell division; • regulation of cell population proliferation; • positive regulation of apoptotic process; • 細胞さいぼう周期しゅうき; • platelet-derived growth factor receptor signaling pathway; • 過酸化水素かさんかすいそへの反応はんのう; • シグナル伝達でんたつ;
	出典しゅってん:Amigo / QuickGO
オルソログ
	10628
	56338
	ENSG00000265972
	ENSMUSG00000038393
	Q9H3M7
	Q8BG60
	NM_006472; NM_001313972
	NM_001009935; NM_023719
	NP_001300901; NP_006463
	NP_001009935; NP_076208
	ウィキデータ
閲覧えつらん/編集へんしゅうヒト	閲覧えつらん/編集へんしゅうマウス

チオレドキシン相互そうご作用さようタンパク質たんぱくしつ（英えい: Thioredoxin-interacting protein, TXNIP）は、ヒト TXNIP 遺伝子いでんしにコードされているタンパク質たんぱくしつである^[5]^[6]。

チオレドキシン結合けつごうタンパク質たんぱくしつ2（英えい: Thioredoxin-binding protein 2, TBP-2）やビタミンD₃上向うわむき制御せいぎょタンパク質たんぱくしつ1（英えい: Vitamin D₃ up-regulated protein 1, VDUP-1）としても知しられている。

相互そうご作用さよう

TXNIPは、チオレドキシン^[7]およびZBTB32（英語えいご版ばん）^[8]と相互そうご作用さようすることが示しめされている。

脚注きゃくちゅう

^ ^a ^b ^c GRCh38: Ensembl release 89: ENSG00000265972 - Ensembl, May 2017
^ ^a ^b ^c GRCm38: Ensembl release 89: ENSMUSG00000038393 - Ensembl, May 2017
^ Human PubMed Reference:
^ Mouse PubMed Reference:
^ Chen KS, DeLuca HF (Oct 1994). “Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3”. Biochim. Biophys. Acta 1219 (1): 26–32. PMID 8086474.
^ “Entrez Gene: TXNIP thioredoxin interacting protein”. 2011年ねん6月がつ3日にち閲覧えつらん。
^ Nishiyama, A; Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, Yodoi J (Jul. 1999), “Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression”, J. Biol. Chem. (UNITED STATES) 274 (31): 21645–50, doi:10.1074/jbc.274.31.21645, ISSN 0021-9258, PMID 10419473
^ Han, Seung Hyun; Jeon Jun Ho, Ju Hyang Ran, Jung Uhee, Kim Kun Young, Yoo Hyang Sook, Lee Young Ho, Song Kyu Sang, Hwang Ho Myeung, Na Yoon Sook, Yang Young, Lee Kee Nyung, Choi Inpyo (Jun. 2003), “VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression”, Oncogene (England) 22 (26): 4035–46, doi:10.1038/sj.onc.1206610, ISSN 0950-9232, PMID 12821938

推薦すいせん文献ぶんけん

Nishiyama A, Matsui M, Iwata S, et al. (1999). “Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression.”. J. Biol. Chem. 274 (31): 21645–50. doi:10.1074/jbc.274.31.21645. PMID 10419473.
Ludwig DL, Kotanides H, Le T, et al. (2001). “Cloning, genetic characterization, and chromosomal mapping of the mouse VDUP1 gene.”. Gene 269 (1-2): 103–12. doi:10.1016/S0378-1119(01)00455-3. PMID 11376942.
Bodnar JS, Chatterjee A, Castellani LW, et al. (2002). “Positional cloning of the combined hyperlipidemia gene Hyplip1.”. Nat. Genet. 30 (1): 110–6. doi:10.1038/ng811. PMC 2846781. PMID 11753387.
Joguchi A, Otsuka I, Minagawa S, et al. (2002). “Overexpression of VDUP1 mRNA sensitizes HeLa cells to paraquat.”. Biochem. Biophys. Res. Commun. 293 (1): 293–7. doi:10.1016/S0006-291X(02)00208-5. PMID 12054598.
Butler LM, Zhou X, Xu WS, et al. (2002). “The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.”. Proc. Natl. Acad. Sci. U.S.A. 99 (18): 11700–5. doi:10.1073/pnas.182372299. PMC 129332. PMID 12189205.
Schulze PC, De Keulenaer GW, Yoshioka J, et al. (2002). “Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin.”. Circ. Res. 91 (8): 689–95. doi:10.1161/01.RES.0000037982.55074.F6. PMID 12386145.
Han SH, Jeon JH, Ju HR, et al. (2003). “VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression.”. Oncogene 22 (26): 4035–46. doi:10.1038/sj.onc.1206610. PMID 12821938.
Champliaud MF, Viel A, Baden HP (2003). “The expression of vitamin D-upregulated protein 1 in skin and its interaction with sciellin in cultured keratinocytes.”. J. Invest. Dermatol. 121 (4): 781–5. doi:10.1046/j.1523-1747.2003.12539.x. PMID 14632196.
Kim KY, Shin SM, Kim JK, et al. (2004). “Heat shock factor regulates VDUP1 gene expression.”. Biochem. Biophys. Res. Commun. 315 (2): 369–75. doi:10.1016/j.bbrc.2004.01.047. PMID 14766217.
Schulze PC, Yoshioka J, Takahashi T, et al. (2004). “Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.”. J. Biol. Chem. 279 (29): 30369–74. doi:10.1074/jbc.M400549200. PMID 15128745.
Coon H, Singh N, Dunn D, et al. (2004). “TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study.”. Atherosclerosis 174 (2): 357–62. doi:10.1016/j.atherosclerosis.2004.02.004. PMID 15136067.
Nishinaka Y, Masutani H, Oka S, et al. (2004). “Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D(3)-up-regulated protein 1.”. J. Biol. Chem. 279 (36): 37559–65. doi:10.1074/jbc.M405473200. PMID 15234975.
Aitken CJ, Hodge JM, Nishinaka Y, et al. (2005). “Regulation of human osteoclast differentiation by thioredoxin binding protein-2 and redox-sensitive signaling.”. J. Bone Miner. Res. 19 (12): 2057–64. doi:10.1359/JBMR.040913. PMID 15537450.
Yamawaki H, Pan S, Lee RT, Berk BC (2005). “Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells.”. J. Clin. Invest. 115 (3): 733–8. doi:10.1172/JCI200523001. PMC 546457. PMID 15696199.
Minn AH, Hafele C, Shalev A (2005). “Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis.”. Endocrinology 146 (5): 2397–405. doi:10.1210/en.2004-1378. PMID 15705778.

この項目こうもくは、生物せいぶつ学がくに関連かんれんした書かきかけの項目こうもくです。この項目こうもくを加筆かひつ・訂正ていせいなどしてくださる協力きょうりょく者しゃを求もとめています（プロジェクト:生命せいめい科学かがく／Portal:生物せいぶつ学がく）。

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000265972 - Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000038393 - Ensembl, May 2017

[3] Human PubMed Reference:

[4] Mouse PubMed Reference:

[pmid8086474-5] Chen KS, DeLuca HF (Oct 1994). “Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3”. Biochim. Biophys. Acta 1219 (1): 26–32. PMID 8086474.

[entrez-6] “Entrez Gene: TXNIP thioredoxin interacting protein”. 2011年ねん6月がつ3日にち閲覧えつらん。

[pmid10419473-7] Nishiyama, A; Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, Yodoi J (Jul. 1999), “Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression”, J. Biol. Chem. (UNITED STATES) 274 (31): 21645–50, doi:10.1074/jbc.274.31.21645, ISSN 0021-9258, PMID 10419473

[pmid12821938-8] Han, Seung Hyun; Jeon Jun Ho, Ju Hyang Ran, Jung Uhee, Kim Kun Young, Yoo Hyang Sook, Lee Young Ho, Song Kyu Sang, Hwang Ho Myeung, Na Yoon Sook, Yang Young, Lee Kee Nyung, Choi Inpyo (Jun. 2003), “VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression”, Oncogene (England) 22 (26): 4035–46, doi:10.1038/sj.onc.1206610, ISSN 0950-9232, PMID 12821938

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]